
Melanoma Marker Antibody (NKI/C3) is a mouse monoclonal IgG1 antibody that detects Melanoma Marker in human samples through various applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and immunohistochemistry with paraffin-embedded sections (IHCP). Melanoma Marker (NKI/C3) monoclonal antibody plays a crucial role in the study of malignant melanoma, a serious form of skin cancer that arises from melanocytes, the pigment-producing cells responsible for melanin synthesis. Understanding Melanoma Marker′s structure is vital, as this protein is involved in critical cellular processes such as cell adhesion and migration, which are essential for the metastasis of melanoma cells. Melanoma Marker′s structure allows for interaction with specific receptors and signaling pathways that regulate cell growth and survival, making this protein a key player in tumor progression. Anti-Melanoma Marker antibody (NKI/C3) helps researchers gain insights into the mechanisms of melanoma development and progression, ultimately aiding in the identification of potential therapeutic targets and improving patient outcomes.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Melanoma Marker Antibody (NKI/C3) | sc-52351 | 200 µg/ml | $322.00 | |||
Melanoma Marker Antibody (NKI/C3): m-IgG Fc BP-HRP Bundle | sc-536853 | 200 µg Ab; 10 µg BP | $361.00 | |||
Melanoma Marker Antibody (NKI/C3): m-IgGκ BP-HRP Bundle | sc-534020 | 200 µg Ab; 40 µg BP | $361.00 | |||
Melanoma Marker Antibody (NKI/C3): m-IgG1 BP-HRP Bundle | sc-544859 | 200 µg Ab; 20 µg BP | $361.00 |